Hidradenitis Suppurativa: all 280 studies

Page 2 of 3. Open to participants first (85), then studies with results posted, then the rest; newest registration first within each.

• A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis SuppurativaCompletedNCT04762277Phase 2Results posted
• Hidradenitis Suppurativa (HS) Tunneling WoundsCompletedNCT04648631Not applicableResults posted
• Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis SuppurativaCompletedNCT04600375Not applicableResults posted
• Optimizing Intralesional Triamcinolone Dosing for Hidradenitis SuppurativaTerminatedNCT04582669Phase 4Results posted
• A Study of LY3041658 in Adults With Hidradenitis SuppurativaCompletedNCT04493502Phase 2Results posted
• To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis SuppurativaCompletedNCT04476043Phase 2Results posted
• HidraWear Study for Hidradenitis Suppurativa WoundsCompletedNCT04449354Not applicableResults posted
• A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease SymptomsCompletedNCT04430855Phase 2Results posted
• Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa TreatmentTerminatedNCT04414514Phase 2Results posted
• Hidradenitis Suppurativa Wound CareCompletedNCT04354012Phase 2Results posted
• Tofacitinib for Immune Skin Conditions in Down SyndromeCompletedNCT04246372Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis SuppurativaCompletedNCT04242498Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis SuppurativaCompletedNCT04242446Phase 3Results posted
• Wound Dressings for Hidradenitis SuppurativaCompletedNCT04194541Not applicableResults posted
• Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis SuppurativaCompletedNCT04179175Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis SuppurativaCompletedNCT04092452Phase 2Results posted
• A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis SuppurativaCompletedNCT04019041Phase 2Results posted
• A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaCompletedNCT03926169Phase 2Results posted
• Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)CompletedNCT03852472Phase 2Results posted
• Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis SuppurativaCompletedNCT03827798Phase 2Results posted
• Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)CompletedNCT03713632Phase 3Results posted
• This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).CompletedNCT03713619Phase 3Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)CompletedNCT03628924Phase 2Results posted
• A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis SuppurativaCompletedNCT03607487Phase 2Results posted
• A Study of the Safety of INCB054707 in Participants With Hidradenitis SuppurativaCompletedNCT03569371Phase 2Results posted
• A Study of Bermekimab in Patients With Hidradenitis SuppurativaCompletedNCT03512275Phase 2Results posted
• Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)CompletedNCT03487276Phase 2Results posted
• Hydroxychloroquine for the Treatment of Hidradenitis SuppurativaCompletedNCT03275870Phase 1/2Results posted
• A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.CompletedNCT03248531Phase 2Results posted
• Low Dose Radiotherapy for Advanced Hidradenitis SuppurativaTerminatedNCT03040804Not applicableResults posted
• Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis SuppurativaCompletedNCT02904902Phase 3Results posted
• Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-SurgicallyCompletedNCT02808975Phase 4Results posted
• Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis SuppurativaCompletedNCT02805595Phase 2Results posted
• A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.CompletedNCT02781818Not applicableResults posted
• Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) PatientsCompletedNCT02739828Results posted
• Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa PatientsCompletedNCT02421172Phase 2Results posted
• Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis SuppurativaTerminatedNCT01838499Phase 2Results posted
• Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis SuppurativaCompletedNCT01635764Phase 3Results posted
• Anakinra as a Treatment for Hydradenitis SuppurativaCompletedNCT01516749Phase 2Results posted
• Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis SuppurativaCompletedNCT01468233Phase 3Results posted
• Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis SuppurativaCompletedNCT01468207Phase 3Results posted
• Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis SuppurativaCompletedNCT00918255Phase 2Results posted
• A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HSTerminatedNCT00722800Phase 2Results posted
• Etanercept for Treatment of HidradenitisCompletedNCT00107991Phase 2Results posted
• A 24-Week Real-World Study of Upadacitinib in Moderate-to-Severe Hidradenitis SuppurativaActive, not recruitingNCT07727889Phase 2
• Comparative Efficacy of Apremilast and Acitretin in Moderate-to-Severe Hidradenitis SuppurativaCompletedNCT07708480Phase 4
• Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.CompletedNCT07428941
• Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and DermatologistsCompletedNCT07428915
• Real-World Study on the Burden of Hidradenitis SuppurativaCompletedNCT07323303
• Periodontal Status and Disease Severity in Hidradenitis Suppurativa PatientsCompletedNCT07294456
• A Study Evaluating BFB759 in Moderate to Severe Hidradenitis SuppurativaActive, not recruitingNCT07287644Phase 2/3
• Molecular Evaluation of TAAR1 and JAK/STAT Pathway in Hidradenitis SuppurativaCompletedNCT07278011
• A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.Active, not recruitingNCT07228390Phase 2
• A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis SuppurativaCompletedNCT07077902Phase 2
• The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.CompletedNCT07046039
• Tibulizumab Skin Healing and Inflammation Evaluation for Lasting DefenseActive, not recruitingNCT06993610Phase 2
• A Study With CIT-013 in HS PatientsActive, not recruitingNCT06993233Phase 2
• Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)Active, not recruitingNCT06959225Phase 3
• Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)Active, not recruitingNCT06958211Phase 3
• Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)Active, not recruitingNCT06956235Phase 2
• A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis SuppurativaActive, not recruitingNCT06921850Phase 3
• A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis SuppurativaActive, not recruitingNCT06840392Phase 3
• Aviclear for Hidradenitis Suppurativa (HS)CompletedNCT06801795Not applicable
• A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)Active, not recruitingNCT06799000Phase 3
• Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.Active, not recruitingNCT06785675
• An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)Active, not recruitingNCT06768671Phase 3
• A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)TerminatedNCT06685835Phase 2
• A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis SuppurativaCompletedNCT06603077Phase 2
• Therapeutic Effect of Methalazine on 27 Cases of Suppurative HidradenitisCompletedNCT06568224
• Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis SuppurativaTerminatedNCT06555328Phase 2
• Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian FederationActive, not recruitingNCT06517732
• A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaActive, not recruitingNCT06468228Phase 3
• Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab InitiationActive, not recruitingNCT06444087
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaCompletedNCT06411899Phase 3
• Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaCompletedNCT06411379Phase 3
• Anifrolumab for Hidradenitis SuppurativaCompletedNCT06374212Phase 2
• Study of Single Doses of SBT777101 in Subjects With Hidradenitis SuppurativaActive, not recruitingNCT06361836Phase 1
• Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEasesCompletedNCT06324695Not applicable
• Botulinum Toxin-A for Hidradenitis SuppurativaWithdrawnNCT06237465Phase 4
• A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis SuppurativaActive, not recruitingNCT06212999Phase 3
• Mindfulness in Hidradenitis SuppurativaCompletedNCT06123429Not applicable
• A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult VolunteersCompletedNCT06082323Phase 1
• A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis SuppurativaCompletedNCT06046729Phase 2
• A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaTerminatedNCT06028230Phase 2
• Physical Activity in Hidradenitis Suppurativa (HS)CompletedNCT06015438Not applicable
• HIDRAdenitis Suppurativa and HEART DiseaseActive, not recruitingNCT05989945
• Validation of the French Version of the Score on Quality of Life (HiSQOL) in Hidradenitis Suppurativa (QUALIVER)CompletedNCT05986825
• Evaluating the Safety and Efficacy of Laight®-Therapy Treatment in Subjects With Hidradenitis SuppurativaCompletedNCT05927948Not applicable
• Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.Active, not recruitingNCT05921994
• The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.CompletedNCT05913817
• A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF TherapyActive, not recruitingNCT05889182Phase 3
• Safety and Treatment of Cryoinsufflation in Treatment of Hidradenitis SuppurativaTerminatedNCT05830149Not applicable
• The Role of Host-microbiota Interplay in Hidradenitis Suppurativa PathogenesisStatus unknownNCT05735925Not applicable
• Autophagy Dysfunction in Hidradenitis SuppurativaStatus unknownNCT05723757Not applicable
• Hidradenitis - an Analysis of Genetic Traits and Linkages in FamiliesTerminatedNCT05710393
• Efficacy and Safety of Infliximab Biosimilar in the Treatment of Resistant Hidradenitis SuppurativaCompletedNCT05663268Early Phase 1
• Mindfulness Training Hidradenitis Suppurativa (HS)CompletedNCT05642039Not applicable
• A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)CompletedNCT05620836Phase 3
• A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis SuppurativaCompletedNCT05620823Phase 3
• Fractional CO2 Laser Fenestration and Steroid Delivery in HS LesionsStatus unknownNCT05580029Early Phase 1

← Hidradenitis Suppurativa overview